DEUTSCHE BANK AG\ - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 7 filers reported holding CHINA PHARMA HLDGS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q4 2019$1,000
-95.8%
6,255
-91.6%
0.00%
Q2 2019$24,000
-66.2%
74,720
-65.2%
0.00%
Q1 2019$71,000214,9000.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 235,000$157,0000.00%
tru Independence LLC 12,500$8,0000.00%
HRT FINANCIAL LP 59,461$39,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
TWO SIGMA SECURITIES, LLC 12,068$8,0000.00%
Renaissance Technologies 838,080$558,0000.00%
UBS Group AG 7,790$5,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders